Risk factors to develop multicentric lesions of the lower genital tract

Purpose of investigation: To analyze which are the risk factors in developing multicentric lesions of lower genital tract. Materials and Methods: A prospective study of 1,011 patients was conducted at the low genital tract pathology clinic of Sant Joan de Deu Hospital between 2003-2011. A complete assessment of cervix, vagina, and vulva was carried out including HPV-DNA testing, cytology study, colposcopy, and biopsy in case of atypical findings. The statistical analysis was done with SPSS v.19 software. Differences between groups were considered statistically significant at p < 0.05. Results: Twenty-two patients presented multicentric lesions (2.2%). The average age was 43 years. Most of the lesions were bicentric affecting cervix and vagina and cervix and vulva. Only in two cases (9%) there were three sites of genital neoplasia. The authors found four cervical cancer, 17 high grade, and one low grade lesions of the cervix. Eighteen vaginal intraepithelial neoplasia (VAIN), six high grade, 14 low grade, and four vulvar intraepithelial neoplasia (VIN) were found. HPV infection, age > 35 years, multiparity, contraceptive method, immunodeficiency, and level of studies were significantly correlated with multicentric lesions. High percentage of affected margins were found. VIN cases were treated with surgical excision and in two cases microinvasion was found. VAIN III cases were treated with surgical excision or with laser and one case progressed to vaginal cancer. Recurrence after treatment was 27%. Conclusion: Age, multiparity, contraceptive method, immunodeficiency, and level of studies were significantly correlated with multicentric lesion. Multicentric lesions had an increased risk of recurrence and progression to cancer.

Multicentric lesions; HPV; Intraepithelial lesions; Recurrence; Cancer.

[1] Torné Bladé A.: “Patología premaligna del cuello uterino”. In: González-Merlo J., González-Bosquet E., González-Bosquet J., (eds). Ginecologia 9thed. Barcelona: Elsevier Masson, 2014, 416.

[2] Cardosi RJ, Bomaslasky JJ, Hoffman MS.: “Diagnosis and management of vulvar and vaginal intraepithelial neoplasia”. Obstet. Gynecol. Clin. North. Am., 2001, 28, 685.

[3] Ait Menguellet S., Collinet P., Houfflin Debarge V., Nayama M., Vinatier D., Leroy J.L.: “Management of multicentric lesions of the lower genital tract”. Eur. J. Obstet. Gynecol. Reprod. Biol. ,2007, 132, 116.

[4] Houfflin Debarge V., Collinet P., Vinatier D., Ego A., Dewilde A., Boman F., Leroy J.L.: “Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions”. Gynecol. Oncol., 2003, 90, 587.

[5] van Beurden M., ten Kate F.W., Tjong-A-Hung S.P., de Craen A.J., van der Vange N., Lammes F.B., et al.: “Human papillomavirus DNA in multicentric vulvar intraepithelial neoplasia”. Int. J. Gynecol. Pathol., 1998, 17, 12.

[6] Walker P., Dexeus S., DePalo G., Barrasso R., Campion M., Girardi F., et al.: “International terminology of colposcopy: An updated report from the International Federation for Cervical Pathology and Colposcopy”. Obstet. Gynecol., 2003, 101, 175.

[7] Audet-Lapointe P., Body G., Vauclair R., Drouin P., Ayoub J.: “Vaginal intraepithelial neoplasia”. Gynecol. Oncol., 1990, 36, 232.

[8] Hampl M., Wentzensen N., Vinokurova S., von Knebel-Doeberitz M., Poremba C., Bender H.G., Kueppers V.: “Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile”. J. Cancer Res. Clin. Oncol., 2007, 133, 235.

[9] Castellsegue X, Muñoz N.: “Co-factors in human papillomavirus carcinogénesis role of parity, oral contraceptives, and tobacco smoking”.: J. Natl. Cancer. Ins. Monogr., 2003, 31, 20.

[10] Rapose A.: “Human papillomavirus and genital cancer”. Indian J. 12 Dermatol. Venereol. Leprol., 2009, 75, 236.

[11] Hørding U, Daugaard S, Iversen AK, Knudsen J, Bock JE, Norrild B.: “Human papillomavirus type 16 in vulvar carcinoma, vulvar intraepithelial neoplasia, and associated cervical neoplasia”. Gynecol. Oncol., 1991, 42, 22.

[12] Lindeque BG.: “Management of cervical premalignant lesions”. Best. Pract. Res. Clin. Obstet. Gynaecol., 2005, 19, 545.

[13] Frega A., Sesti F., Sopracordevole F., Biamonti A., Votano S., Catalano A., et al.: “Multiple intraepithelial neoplasias of the lower female genital tract: the reliability of HPV mRNA test”. J. Low. Genit. Tract. Dis., 2014, 18, 174.

[14] Fallani M.G., Fambrini M., Zipoli E., Marchionni M.: “CO2 laser surgery for vulvar intraepithelial neoplasia. Excisional, destructive and combined techniques”. J. Reprod. Med., 2002, 47, 913.

[15] Melkert P.W., Walboomers J.M., Jiwa N.M., Cuesta M.A., Kenemans P., Meijer C.J.: “Multiple HPV 16-related squamous cell carcinomas of the vulva, vagina, anus, skin and cervix in a 31-year-old woman”. Eur. J. Obstet. Gynecol. Reprod.Biol., 1992, 46, 53.

[16] Henning E.M., Di Lonardo A., Venuti A., Holm R., Marcante M.L., Nesland J.M.: “HPV 16 in multiple neoplastic lesions in women with CIN III”. J. Exp. Clin. Cancer. Res., 1999, 18, 369.